AXIOS M00553650 50270

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-02-26 for AXIOS M00553650 50270 manufactured by Boston Scientific Corporation.

Event Text Entries

[188831132] (b)(6). (b)(4). The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed. If any further relevant information is identified, a supplemental medwatch will be filed.
Patient Sequence No: 1, Text Type: N, H10


[188831133] It was reported to boston scientific corporation on (b)(6) 2020 that a hot axios stent was to be implanted in a transgastric position to treat a pancreatic pseudocyst during a pancreatic cyst drainage procedure performed on (b)(6) 2020. Reportedly, the physician was using the eus method of deployment where the second flange of the stent is deployed in the scope, and then the stent is released from the scope by advancing the catheter and retracting the scope in a 1:1 fashion. According to the complainant, during the procedure, puncture was performed using an fna needle and the guidewire was placed in the cyst. The axios stent was advanced along the guidewire and the first flange was deployed on the cyst side. The delivery system was pulled up to the stomach wall and the second flange was deployed in the scope. Reportedly, the physician had trouble releasing the second flange out from the scope; the delivery system was pushed several times and after distance was obtained, the flange was able to be deployed. Cyst fluid was found to be leaking into the stomach. When the fluoroscopic image was reviewed, it was confirmed that the stent had moved out from its original position into the anal side inside the cyst. The guidewire remained providing access to the cyst, and a second axios stent of 20mm size was placed to complete the procedure. On (b)(6) 2020, fistula was dilated using a cre 15mm balloon catheter and the scope was inserted into the cyst. The migrated stent was then successfully removed using a grasping forceps. Reportedly, the recorded eus video of the placement procedure was reviewed and it was confirmed that the stent was deployed into the cyst side at the same time when the delivery system was pushed. There were no patient complications reported from the first placement up to the retrieval of the stent.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005099803-2020-00536
MDR Report Key9759434
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-02-26
Date of Report2020-02-26
Date of Event2020-02-03
Date Mfgr Received2020-02-03
Device Manufacturer Date2019-11-20
Date Added to Maude2020-02-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCAROLE MORLEY
Manufacturer Street300 BOSTON SCIENTIFIC WAY
Manufacturer CityMARLBOROUGH MA 01752
Manufacturer CountryUS
Manufacturer Postal01752
Manufacturer Phone5086834015
Manufacturer G1BOSTON SCIENTIFIC CORPORATION
Manufacturer StreetBALLYBRIT BUSINESS PARK
Manufacturer CityGALWAY
Manufacturer CountryEI
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAXIOS
Generic NamePANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Product CodePCU
Date Received2020-02-26
Model NumberM00553650
Catalog Number50270
Lot Number0024798877
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBOSTON SCIENTIFIC CORPORATION
Manufacturer Address300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 US 01752


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-02-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.